Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (30)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Totsuka, Y.
Right arrow Articles by Wakabayashi, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Totsuka, Y.
Right arrow Articles by Wakabayashi, K.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol 19, 1995-2000, Copyright © 1998 by Oxford University Press


ARTICLES

Structural determination of a mutagenic aminophenylnorharman produced by the co-mutagen norharman with aniline

Y Totsuka, N Hada, K Matsumoto, N Kawahara, Y Murakami, Y Yokoyama, T Sugimura and K Wakabayashi
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan. ytotsuka@gan2.ncc.go.jp

Norharman (9H-pyrido[3,4-b]indole), widely distributed in our environment, including cigarette smoke and cooked foodstuffs, is not mutagenic to Salmonella strains, but becomes mutagenic to S.typhimurium TA98 and YG1024 with S9 mix in the presence of non-mutagenic aromatic amines such as aniline and o-toluidine. To elucidate the mechanisms of co-mutagenicity, we tried to isolate the mutagen(s) produced by a reaction between norharman and aniline with S9 mix. By HPLC purification, two mutagenic compounds (I and II), one (I) showing mutagenicity with and the other (II) without S9 mix, were isolated. The structure of compound I was deduced to be a coupled compound of norharman and aniline, 9-(4'-aminophenyl)-9H-pyrido[3,4-b]indole (aminophenylnorharman), by a variety of spectrometry techniques and this was confirmed by its chemical synthesis. The mutagenic activity of this novel heterocyclic amine was tested using the pre-incubation method and was found to induce 187,000 revertants in TA98 and 1,783,000 revertants in YG1024 per microg with S9 mix. Compound II was shown to be hydroxyaminophenylnorharman. Formation of the same DNA adducts was observed in YG1024 when aminophenylnorharman or a mixture of norharman plus aniline was incubated with S9 mix. The hydroxyamino derivative also yielded the same DNA adducts in YG1024. Thus, the appearance of mutagenicity by norharman with aniline in the presence of S9 mix suggests that the coupled mutagenic compound, aminophenylnorharman, is formed from norharman and aniline, then converted to the hydroxyamino derivative and forms DNA adducts to induce mutations in TA98 and YG1024.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
R. Nishigaki, Y. Totsuka, H. Kataoka, H. Ushiyama, S. Goto, T. Akasu, T. Watanabe, T. Sugimura, and K. Wakabayashi
Detection of Aminophenylnorharman, a Possible Endogenous Mutagenic and Carcinogenic Compound, in Human Urine Samples
Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
Y. Oda, Y. Totsuka, K. Wakabayashi, F.P. Guengerich, and T. Shimada
Activation of aminophenylnorharman, aminomethylphenylnorharman and aminophenylharman to genotoxic metabolites by human N-acetyltransferases and cytochrome P450 enzymes expressed in Salmonella typhimurium umu tester strains
Mutagenesis, November 1, 2006; 21(6): 411 - 416.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
T. Kawamori, Y. Totsuka, N. Uchiya, T. Kitamura, H. Shibata, T. Sugimura, and K. Wakabayashi
Carcinogenicity of aminophenylnorharman, a possible novel endogenous mutagen, formed from norharman and aniline, in F344 rats
Carcinogenesis, October 1, 2004; 25(10): 1967 - 1672.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K.-i. Masumura, Y. Totsuka, K. Wakabayashi, and T. Nohmi
Potent genotoxicity of aminophenylnorharman, formed from non-mutagenic norharman and aniline, in the liver of gpt delta transgenic mouse
Carcinogenesis, December 1, 2003; 24(12): 1985 - 1993.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.